- Home
- CRT vs CCEL Comparison
CRT vs CCEL Comparison
Compare CRT & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- CCEL
- Stock Information
- Founded
- CRT 1991
- CCEL 1989
- Country
- CRT United States
- CCEL United States
- Employees
- CRT N/A
- CCEL N/A
- Industry
- CRT Oil & Gas Production
- CCEL Managed Health Care
- Sector
- CRT Energy
- CCEL Health Care
- Exchange
- CRT Nasdaq
- CCEL Nasdaq
- Market Cap
- CRT 60.7M
- CCEL 50.0M
- IPO Year
- CRT 1992
- CCEL 1997
- Fundamental
- Price
- CRT $9.90
- CCEL $7.80
- Analyst Decision
- CRT
- CCEL
- Analyst Count
- CRT 0
- CCEL 0
- Target Price
- CRT N/A
- CCEL N/A
- AVG Volume (30 Days)
- CRT 29.6K
- CCEL 10.6K
- Earning Date
- CRT 01-01-0001
- CCEL 01-07-2025
- Dividend Yield
- CRT 10.32%
- CCEL 3.23%
- EPS Growth
- CRT N/A
- CCEL N/A
- EPS
- CRT 1.13
- CCEL N/A
- Revenue
- CRT $7,711,133.00
- CCEL $31,838,476.00
- Revenue This Year
- CRT N/A
- CCEL $3.97
- Revenue Next Year
- CRT N/A
- CCEL $0.91
- P/E Ratio
- CRT $8.68
- CCEL N/A
- Revenue Growth
- CRT N/A
- CCEL 1.95
- 52 Week Low
- CRT $8.88
- CCEL $4.47
- 52 Week High
- CRT $18.49
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- CRT 46.72
- CCEL 44.48
- Support Level
- CRT $9.27
- CCEL $7.66
- Resistance Level
- CRT $9.92
- CCEL $9.10
- Average True Range (ATR)
- CRT 0.33
- CCEL 0.25
- MACD
- CRT -0.02
- CCEL -0.10
- Stochastic Oscillator
- CRT 60.00
- CCEL 15.87
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.